Enabling Therapeutics — Market Opportunities
Enabling Therapeutics
Enzo’s proprietary therapeutic platforms are positioned to address significant unmet medical needs across multiple high-value therapeutic areas, from immuno-oncology to rare genetic diseases.
Addressing High-Value Therapeutic Markets
Enzo Therapeutics combines a unique portfolio of proprietary platform technologies with vertically integrated R&D and GMP manufacturing capabilities. This positions us to create value across multiple therapeutic areas where our immune regulation, gene technology, and cell signaling modulation platforms offer differentiated approaches to critical unmet medical needs. Our strategic focus targets indications where Enzo’s deep expertise and intellectual property provide sustainable competitive advantages.
Oncology & Immuno-Oncology
Novel checkpoint modulators, epigenetic therapeutics, and immune activators for solid and hematologic malignancies. Our FLUOR DE LYS-derived HDAC inhibitors and SCREEN-WELL-identified kinase inhibitors address tumor cell proliferation, while our immune regulation platform enables combination immunotherapy approaches.
Autoimmune & Inflammatory
Targeted immunomodulatory approaches for rheumatoid arthritis, lupus, multiple sclerosis, and inflammatory bowel disease. Alequel oral tolerization offers a differentiated mechanism for inducing disease-specific immune tolerance without broad immunosuppression — a major advantage over current standard-of-care therapies.
Neurodegenerative Diseases
Cell signaling modulators targeting neuroinflammation, protein aggregation, and neurodegeneration pathways in Alzheimer’s, Parkinson’s, and ALS. Our SCREEN-WELL Autophagy Library and HDAC inhibitor programs address key mechanisms underlying neuronal cell death and cognitive decline.
Gene Therapy & Rare Diseases
Nucleic acid therapeutic platforms for orphan indications where Enzo’s proprietary modified nucleotides and gene delivery systems offer unique advantages. AMPIVIEW companion diagnostics enable patient stratification and therapeutic monitoring for precision gene therapy approaches.
Enabling Therapeutics — By the Numbers
Explore Partnership Opportunities
Connect with our business development team to explore licensing, co-development, and technology transfer opportunities across our therapeutic platforms.